Page 72 - P4403.14-V111 December OTC Magazine 2025 - Digital 1
P. 72

72  SEXUAL HEALTH


                                                                              Buying       Trade    POR
                                                  Product                Size  Price/  RRP  Offer      Pip Code
                                                                               Single       %     %
                                                  ELLAONE
                                                             EllaOne 30mg   1  £12.67  £34.95  10%  56%  3478708







               Be her pharmacy


                                  answers



                                  guidance



                                  solution


                                  comfort



                                  support

                                                                                         10%



                                                                                          POR



















               SCAN FOR
               TRAINING                                          2.5x more effective

                                                                       than levonorgestrel             1


                                                                     Support your pharmacy to help women
                                                                         with their contraceptive needs

               perrigowomenshealth.co.uk                               1. Glasier A et al. Lancet 2010; 375(9714):555-62.



             ESSENTIAL INFORMATION:
             PRODUCT INFORMATION: ellaOne® 30 mg film-coated tablet (ulipristal acetate). Refer to the SmPC for further information. INDICATION: Emergency contraception (EC) within 120 hours (5 days)
             of unprotected sexual intercourse or contraceptive failure. Information about this product, including adverse reactions, precautions, contra-indications, and method of use can be found at: https://
             mhraproducts4853. blob.core.windows.net/docs/b0731d06d3693ecfbd3c4d15547cba88d0f7de6c MARKETING AUTHORISATION HOLDER: Laboratoire HRA Pharma, 200 avenue de Paris, 92320
             Châtillon, France. MARKETED IN THE UK BY: HRA Pharma a Perrigo Company, One Embassy Gardens, Viaduct Gardens, Nine Elms, London SW11 7BW, United Kingdom LEGAL CATEGORY: P
             Date of last revision of text: October 2023. Unique ID: UK/ELLA/1672
                             Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
                               Adverse events should also be reported to HRA Pharma on 0800 917 9548 or email HRA-UK@cambreg.co.uk
             Date of preparation: February 2024. Code: UK/ELLA/1719.
   67   68   69   70   71   72   73   74   75   76   77